Status:
UNKNOWN
Precision Therapy in Complex High-risk Coronary Artery Disease
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
This is a prospective registry to enroll complex high-risk coronary heart disease patients. The purpose of this study is to compare intracoronary physiology and imaging-guided intervention strategy a...
Eligibility Criteria
Inclusion
- Bifurcation lesions with branch diameter ≥2.5mm;
- Chronic complete occlusion (occlusion duration ≥3 months);
- Left main disease;
- Long lesions (≥38mm);
- Multi-vessel percutaneous coronary intervention (simultaneous treatment of ≥2 epicardial vessels during one operation);
- Multi-stent implantation (≥3 stents);
- In-stent restenosis;
- Moderate to severe calcification on radiography;
- Intermediate lesion;
- Thrombotic lesions;
- Creatinine clearance rate \< 60ml/min) or on dialysis ;
- Left ventricular ejection fraction \<40% ；
- History of cerebral hemorrhage or massive hemorrhage of gastrointestinal tract.
Exclusion
- Informed consent cannot be obtained;
- Life expectancy \< 1 year.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04444960
Start Date
July 1 2020
End Date
December 1 2023
Last Update
August 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710061